Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ · Healthcare
Recursion Pharmaceuticals, Inc. Shareholder Equity 2019–2025
Recursion Pharmaceuticals, Inc. annual/quarterly shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Recursion Pharmaceuticals, Inc. shareholder equity for the quarter ending December 31, 2025 were 1.13B, a 9.29% increase year-over-year.
- Recursion Pharmaceuticals, Inc. shareholder equity for 2025 were 1.13B, a 9.29% increase from 2024.
- Recursion Pharmaceuticals, Inc. shareholder equity for 2024 were 1.03B, a 123.28% increase from 2023.
- Recursion Pharmaceuticals, Inc. shareholder equity for 2023 were 463.4M, a 4.60% decrease from 2022.
- Recursion Pharmaceuticals, Inc. shareholder equity for 2022 were 485.8M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Recursion Pharmaceuticals, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $1,131 |
| 2024 | $1,035 |
| 2023 | $463 |
| 2022 | $486 |
| 2021 | $543 |
| 2020 | $-206 |
| Recursion Pharmaceuticals, Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $1,131 |
| 2024-12-31 | $1,035 |
| 2023-12-31 | $463 |
| 2022-12-31 | $486 |
| 2021-12-31 | $543 |
| 2020-12-31 | $-206 |
Recursion Pharmaceuticals, Inc. Shareholder Equity — FAQ
Recursion Pharmaceuticals, Inc. (RXRX) shareholder equity over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RXRX's shareholder equity history?
The chart and table above show Recursion Pharmaceuticals, Inc.'s shareholder equity by year and by quarter, including the growth rate.